The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity
Open accessAbstract
The renin-angiotensin-aldosterone system (RAAS) is a major regulator of blood pressure. The octapeptide angiotensin II (AII) is proteolytically processed from the decapeptide AI by angiotensin-converting enzyme (ACE), and then acts via angiotensin type 1 and type 2 receptors (AT1R and AT2R). Inhibitors of ACE and antagonists of the AT1R are used in the treatment of hypertension, myocardial infarction, and stroke. We now show that the RAAS also plays a major role in autoimmunity, exemplified by multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Using proteomics, we observed that RAAS is up-regulated in brain lesions of MS. AT1R was induced in myelin-specific CD4 + T cells and monocytes during autoimmune neuroinflammation. Blocking AII production with ACE inhibitors or inhibiting AII signaling with AT1R blockers suppressed autoreactive TH1 and TH17 cells and promoted antigen-specific CD4+FoxP3+ regulatory T cells (T reg cells) with inhibition of the canonical NF-κB1 transcription factor complex and activation of the alternative NF-κB2 pathway. Treatment with ACE inhibitors induces abundant CD4+FoxP3+ T cells with sufficient potency to reverse paralytic EAE. Modulation of the RAAS with inexpensive, safe pharmaceuticals used by millions worldwide is an attractive therapeutic strategy for application to human autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736 · cited 2×
“AT1R-expressing T cells may be crucial for promoting hypertension, vascular inflammation, and atherosclerosis (8).”
BackgroundResultSteinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Self-citationNatural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
Crystal structure of the human angiotensin-converting enzyme–lisinopril complex
Natesh, R., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2003) · Nature · doi:10.1038/nature01370 · Cited by 888
Cytokine Signaling Modules in Inflammatory Responses
O'Shea, J. J., & Murray, P. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.002 · Cited by 818
Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R.-P., Lira, S. A., & Bravo, R. (1995) · Cell · doi:10.1016/0092-8674(95)90416-6 · Cited by 806
SOCS1/JAB Is a Negative Regulator of LPS-Induced Macrophage Activation
Kinjyo, I., Hanada, T., Inagaki-Ohara, K., Mori, H., Aki, D., Ohishi, M., Yoshida, H., Kubo, M., & Yoshimura, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00446-6 · Cited by 630 · cited 1×
“Because SOCS-1 negatively regulates NF- B (20) and the proinflammatory effects of AII have been attributed to the activation of NF- B, we tested the hypothesis that NF- B is involved in the induction of Treg cells mediated by blocking AT1R signals in antigen-specific T cells.”
BackgroundStat3 and Stat4 Direct Development of IL-17-Secreting Th Cells
Mathur, A. N., Chang, H.-C., Zisoulis, D. G., Stritesky, G. L., Yu, Q., O’Malley, J. T., Kapur, R., Levy, D. E., Kansas, G. S., & Kaplan, M. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4901 · Cited by 555
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
Han, M. H., Hwang, S.-I., Roy, D. B., Lundgren, D. H., Price, J. V., Ousman, S. S., Fernald, G. H., Gerlitz, B., Robinson, W. H., Baranzini, S. E., et al. (2008) · Nature · doi:10.1038/nature06559 · Cited by 516
Self-citationLoss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Self-citationAutoimmune and Inflammatory Mechanisms in Atherosclerosis
Wick, G., Knoflach, M., & Xu, Q. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104644 · Cited by 431
Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y., Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y., & Kishimoto, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15577 · Cited by 281
Design of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277
Self-citationHistory of the design of captopril and related inhibitors of angiotensin converting enzyme.
Cushman, D. W., & Ondetti, M. A. (1991) · Hypertension · doi:10.1161/01.hyp.17.4.589 · Cited by 270
Human regulatory T cells and their role in autoimmune disease
Baecher‐Allan, C., & Hafler, D. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00417.x · Cited by 266
Chitnis, T., Najafian, N., Benou, C., Salama, A. D., Grusby, M. J., Sayegh, M. H., & Khoury, S. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12563 · Cited by 229
Design of angiotensin converting enzyme inhibitors
Cushman, D. W., & Ondetti, M. A. (1999) · Nature Medicine · doi:10.1038/13423 · Cited by 213
Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation
Hilliard, B. A., Mason, N., Xu, L., Sun, J., Lamhamedi-Cherradi, S.-E., Liou, H.-C., Hunter, C., & Chen, Y. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215254 · Cited by 181
Nishikomori, R., Usui, T., Wu, C.-Y., Morinobu, A., O’Shea, J. J., & Strober, W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4388 · Cited by 169
Mazzolai, L., Duchosal, M. A., Korber, M., Bouzourène, K., Aubert, J. F., Hao, H., Vallet, V., Brunner, H. R., Nussberger, J., Gabbiani, G., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000140269.55873.7b · Cited by 139
Luo, J., Ho, P. P.-K., Buckwalter, M. S., Hsu, T., Lee, L. Y., Zhang, H., Kim, D., Kim, S., Gambhir, S. S., Steinman, L., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31763 · Cited by 115
Self-citationRé, R. N. (2004) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0012 · Cited by 103
Sagawa, K., Nagatani, K., Komagata, Y., & Yamamoto, K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21040 · Cited by 83 · cited 1×
“Administration of AT1R blockers suppressed antigen-specific T-cell responses and prevented and reversed collagen-induced arthritis (24, 25).”
BackgroundGage, J. R., Fonarow, G. C., Hamilton, M. A., Widawski, M., Martı́nez-Maza, O., & Vredevoe, D. L. (2004) · NeuroImmunoModulation · doi:10.1159/000076766 · Cited by 81
Mujtaba, M. G., Flowers, L. O., Patel, C. B., Patel, R. A., Haider, M. I., & Johnson, H. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5077 · Cited by 78
Constantinescu, C. S., Ventura, E. S., Hilliard, B. A., et al. (1995) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979509016382 · Cited by 65
The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis
Dalbeth, N. (2005) · Rheumatology · doi:10.1093/rheumatology/keh398 · Cited by 61
Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Constantinescu, C. S., Goodman, D. B. P., Grossman, R. I., Mannon, L. J., & Cohen, J. A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550200068012 · Cited by 55
Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells
Catlett, I., & Hedrick, S. (2005) · Nature Immunology · doi:10.1038/ni1211 · Cited by 45
Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis
Lovrečić, L., Ristič, S., Čizmarević, N. S., Jazbec, S. Š., Sepčić, J., Kapović, M., & Peterlin, B. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00711.x · Cited by 22
Cited by
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells
Kleinewietfeld, M., Manzel, A., Titze, J., Kvakan, H., Yosef, N., Linker, R. A., Muller, D. N., & Hafler, D. A. (2013) · Nature · doi:10.1038/nature11868 · Cited by 1,394
Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction
Madhur, M. S., Lob, H. E., McCann, L. A., Iwakura, Y., Blinder, Y., Guzik, T. J., & Harrison, D. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145094 · Cited by 827
Angiotensin II revisited: new roles in inflammation, immunology and aging
Benigni, A., Cassis, P., & Remuzzi, G. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000080 · Cited by 757
Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells
Hernandez, A. L., Kitz, A., Wu, C., Lowther, D. E., Rodriguez, D. M., Vudattu, N., Deng, S., Herold, K. C., Kuchroo, V. K., Kleinewietfeld, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81151 · Cited by 338
Bernstein, K. E., Ong, F. S., Blackwell, W.-L. B., Shah, K. H., Giani, J. F., Gonzalez-Villalobos, R. A., Shen, X. Z., & Fuchs, S. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006809 · Cited by 324
Metadata
- Authors
- Platten, M., Youssef, S., Hur, E. M., Ho, P. P., Han, M. H., Lanz, T. V., Phillips, L. K., Goldstein, M. J., Bhat, R., Raine, C. S., Sobel, R. A., & Steinman, L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-09
- Volume
- 106
- Issue
- 35
- Pages
- 14948-14953
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2107779094
- Cited by
- 321
- References
- 32
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.